Wikidata

(Q74204403)

English

Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

scientific article published on 01 July 2000

In more languages

Statements

title
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952488
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952488%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q74204403&oldid=1807480388"